ABVC BIOPHARMA, INC. quarterly report, Q2 FY2014

Business context and reporting period

The supplied filing is Ecology Coatings, Inc.’s Form 10-Q, not an ABVC Biopharma filing. It reports the quarter and six months ended March 31, 2014, with comparative 2013 results. The company was in Chapter 7 bankruptcy proceedings during the reporting period and describes itself as a debtor in possession. The report was signed April 17, 2015.

The filing says the company later emerged from bankruptcy in September 2014 with its corporate shell as its only asset; it states that subsequent filings would use that date as a fresh-start date. The operating-business description and financial results in this report therefore do not describe the company after that change.

Key financial metrics

MetricThree months ended March 31Six months ended March 31
Revenue, 2014 / 2013$0 / $761$0 / $7,787
Operating expenses, 2014 / 2013$30 / $21,213$40 / $165,673
Net loss, 2014 / 2013$30 / $104,276$40 / $190,442
Net loss available to common shareholders, 2014 / 2013$30 / $107,624$40 / $197,138
Basic and diluted loss per share$(0.00) in both periods$(0.00) in both periods
Net cash used in operating activities, 2014 / 2013Six months: $40 / $37,598

At March 31, 2014, cash was $578, accounts receivable $1,238, total assets $231,929, liabilities subject to compromise $2,112,143, and shareholders’ deficit $1,880,214. Cash was $618 at September 30, 2013. Net property and equipment was $37,249 and net intangible assets were $192,864. The filing does not provide a clear breakdown of current liabilities, so a current ratio cannot be determined. Margins are not meaningful with no 2014 revenue.

Material changes versus the prior comparable period

  • Revenue fell to zero in both 2014 comparison periods.
  • Reported expenses and losses were sharply lower than in 2013, which management attributed to reduced staffing and insurance costs, as well as no interest expense while in bankruptcy proceedings.
  • For the six months, cash declined by $40 to $578; there were no investing or financing cash flows reported. The comparable 2013 period included $25,000 of debt proceeds.

Outlook, risks, contingencies and unusual items

  • Management disclosed substantial doubt about the company’s ability to continue as a going concern, citing losses, working-capital deficits, negative cash flows, and the Chapter 7 filing. The company reported that liabilities exceeded assets by approximately $1.9 million.
  • The filing says debts in excess of assets were settled and the corporate shell remained as the company’s only asset. It also says new management arranged small working-capital loans to support required filings while determining a new direction; no amount or detailed business outlook is provided.
  • Risks include the inability to launch a new business plan, raise capital, meet filing obligations, commercialize technology, or resume revenue-generating operations. The filing provides no specific revenue or earnings guidance.
  • Disclosure controls were reported ineffective because the small finance staff lacked segregation of duties. The filing says transactions during bankruptcy required court approval.
  • The filing reports no commitments or contingencies, legal proceedings, related-party transactions, or equity issuance for the quarter. It records no interest or income taxes paid in the six-month period.

Important facts for investors to verify

  • Confirm the issuer and filing: the supplied document is for Ecology Coatings, Inc., not ABVC Biopharma, Inc.
  • Reconcile bankruptcy dates and descriptions: the filing refers to a May 15, 2013 Chapter 7 filing, a September 10, 2014 debt settlement, and emergence on September 19, 2014.
  • Verify the post-bankruptcy fresh-start financial statements, the reported debt settlement, and the company’s current assets, liabilities, business plan, and funding arrangements.
  • Check the filing’s reporting compliance and share-count disclosures. It marks “No” for having filed all required reports, while the cover page gives a share-count date of December 31, 2014, after the reported quarter.